VetSRev
Database of veterinary systematic reviews
Database of veterinary systematic reviews
Acta Tropica (2021) 222: 222
DOI: 10.1016/j.actatropica.2021.106048
Praziquantel (PZQ), the only choice of chemotherapy for schistosomiasis recommended by World Health Organization (WHO), has been widely used over 40 years. The long-term, and rapid expansion of, PZQ use for disease control across a large populations continues to raise concern regarding the potential for emergence and establishment of drug resistance. Recent research has also proposed that the long survival and low sensitivity of unpaired worms, derived from either incomplete treatment cure rates or single-sex schistosome infections within final hosts, could exacerbate the risk of PZQ resistance (PZQ-R) emerging. With the aim of assessing whether PZQ efficacy amongst S. japonicum may have changed over time in China, we performed a unique systematic review and meta-analyses on datasets which evaluated the efficacy of PZQ via laboratory assays of field S. japonicum isolates on experimental mice over time. Relevant published literatures from four electronic bibliographic databases and lists of article references were searched. Two indexes, d, a measure used in meta-analyses for worm burden difference between two groups, and r, a traditional measure for worm reduction percentage after treatment but without considering sample size were calculated for each study. A total of 25 papers including 127 experimental studies with eligible data on 2230 mice were retrieved. The pooled d (D) was 3.91 (3.56-4.25) and pooled r (R) was 54.52% (52.55%-56.52%). D significantly increased over time, whereas R non-significantly decreased; both estimates were significantly associated with the total drug dose. Such findings suggested no evidence of PZQ-R emergence S. japonicum to date. However, we consider the potential role of parasite origins, PZQ dosage, and single versus mixed gender infections of the results published to date, and the avenues now needed for further research.
Yu, Q. F., Zhang, J. Y., Sun, M. T., Gu, M. M., Zou, H. Y., Webster, J. P., & Lu, D. B. (2021). In vivo praziquantel efficacy of Schistosoma japonicum over time: a systematic review and meta-analysis. Acta Tropica, 222, 222. https://doi.org/10.1016/j.actatropica.2021.106048 China, disease control, meta-analysis, animal models, man, systematic reviews, drug resistance, human diseases, helminthoses, helminths, infections, parasites, parasitoses, laboratory animals, disease models, drug therapy, survival, efficacy, trematode infections, chemotherapy, Animal and in vitro Models for Pharmaceuticals [VV450], Animal Models of Human Diseases [VV400], Pesticides and Drugs, parasitic diseases, parasitic infestations, parasitosis, People’s Republic of China, Protozoan, Helminth and Arthropod Parasites of Humans [VV220], parasitic worms, Control [HH405], mice, fluke infections, Trematoda, bilharzia, bilharziasis, Schistosoma, schistosomiasis, schistosomosis, snail-borne diseases, anthelmintics, diseases, praziquantel, Schistosoma japonicum